Franklin M Wu, Daniel Gorelik, Michael J Brenner, Masayoshi Takashima, Amit Goyal, Ashley E Kita, Austin S Rose, Robert S Hong, Waleed M Abuzeid, Peter S Maria, Ahmed A Al-Sayed, Michael E Dunham, Prajoy Kadkade, Scott R Schaffer, Alan W Johnson, Adrien A Eshraghi, Shireen Samargandy, Robert J Morrison, Philip A Weissbrod, Margaret B Mitchell, Cyrus C Rabbani, Neil Futran, Omar G Ahmed
OBJECTIVE: To review new drugs and devices relevant to otolaryngology approved by the Food and Drug Administration (FDA) in 2022. DATA SOURCES: Publicly available FDA data on drugs and devices approved in 2022. REVIEW METHODS: A preliminary screen was conducted to identify drugs and devices relevant to otolaryngology. A secondary screen by members of the American Academy of Otolaryngology-Head and Neck Surgery's (AAO-HNS) Medical Devices and Drugs Committee differentiated between minor updates and new approvals...
2024: OTO Open